SEARCH RESULTS FOR: "Tag: IMGN"
REFINE YOUR SEARCH:
RECENT
Last Month(2)
ARTICLES/BLOGS
2019(2)
2018(3)
2017(4)
2015(10)
CATEGORIES
Analyst Downgrades(1)
Analyst Update(1)
Analyst Upgrades(2)
By the Numbers(1)
Ezines(1)
General(2)
Intraday Option Activity(3)
Market Recap(1)
Midday Market Check(2)
Quantitative Analysis(2)
Stocks On the Move(4)
Technical Analysis(3)
Kroger Stock Pivots Lower After Amazon Grocery Report
https://www.schaeffersresearch.com/content/news/2019/03/01/kroger-stock-pivots-lower-after-amazon-grocery-report
3/1/2019 2:25 PM
The Dow is enjoying solid gains today, while the Nasdaq eyes yet another weekly win. But it's not all sunshine and rainbows, as grocery stock Kroger Co (NYSE:KR), biotech ImmunoGen, Inc. (NASDAQ:IM...
China Trade Hopes Lift Dow; Nasdaq Eyes Another Weekly Win
https://www.schaeffersresearch.com/content/ezines/2019/03/01/china-trade-hopes-lift-dow-nasdaq-eyes-another-weekly-win
3/1/2019 12:04 PM
A tame reading on the Fed-watched personal consumption expenditures (PCE) index and hopes for a U.S.-China trade deal have markets cautiously higher this afternoon. However, lackluster data on U...
Buy The Dip On These 2 Biotech Stocks
https://www.schaeffersresearch.com/content/analysis/2018/07/25/buy-the-dip-on-these-2-biotech-stocks
7/25/2018 2:13 PM
Two biotech names to watch in the next month are Array Biopharma Inc (NASDAQ:ARRY) and ImmunoGen, Inc. (NASDAQ:IMGN). Both stocks have struggled recently, but could both be poised to snap out of the...
ImmunoGen Stock Pullback Could Be a Buying Opportunity
https://www.schaeffersresearch.com/content/analysis/2018/04/13/immunogen-stock-pullback-could-be-a-buying-opportunity
4/13/2018 2:42 PM
ImmunoGen, Inc. (NASDAQ:IMGN) is struggling today, down 2.3% to trade at $10.24. The biotech stock raced to a two-year high of $13.41 on March 26, but promptly pulled back in the past two weeks. If hi...
2 Biotech Stocks That Could Burst Higher
https://www.schaeffersresearch.com/content/analysis/2018/02/23/2-biotech-stocks-that-could-burst-higher
2/23/2018 1:18 PM
ImmunoGen, Inc. (NASDAQ:IMGN) shares have been on a tear in 2018, advancing more than 75% already this year. What's more, IMGN stock could have room to run, if recent history is any indicator. Meanwhi...
Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.
More About
Schaeffer's
Contact
Us
Partner Center